We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
FIGS' active customers rose 13.2% to 3.1 million, while revenue per customer hit a record $229.
Scrubwear sales grew 26.5%, while non-scrubwear revenues jumped 40.3% on strong apparel demand.
Product innovation and repeat purchases supported 28.8% revenue growth and a higher 2026 sales outlook.
FIGS, Inc. (FIGS - Free Report) is deepening its connection with healthcare professionals through products that combine practical improvements with fresh design. Its innovation strategy spans fit, fabric, comfort and functionality, alongside new styles and colors. Management highlighted positive customer feedback on fit enhancements, while wider-leg scrub pants, new waistband options and expanded layering choices are broadening the brand’s appeal.
The second-quarter 2026 customer metrics point to stronger engagement. Active customers increased 13.2% year over year to 3.1 million, while purchase frequency continued to improve. Trailing 12-month revenues per active customer rose 10.1% to a record $229. Returning customers were a particular source of strength, shopping more frequently and moving into higher spending levels.
This momentum extended across product categories. Scrubwear revenues grew 26.5% to $161.2 million, with gains across core franchises and limited-edition offerings. Non-scrubwear revenues increased 40.3% to $35.4 million, supported by underscrubs and outerwear. A broader wardrobe gives FIGS more opportunities to meet customers’ needs throughout the workday and encourage purchases beyond their essential scrubs.
Fabric development is reinforcing that strategy. FIGS is complementing its established FIONx offering with FORMx and the newer FIBREx to address different professional needs. Limited-edition launches also generate excitement while drawing attention to core products. Average order value rose 8.5% to $127, primarily reflecting pricing and favorable product mix, adding to the evidence of stronger customer spending.
These developments accompanied revenue growth of 28.8% to $196.6 million, marking FIGS’ third consecutive quarter of growth above 25%. The company also raised its full-year revenue growth outlook to approximately 20%. With an expanding assortment, positive product feedback and more frequent purchasing, FIGS is strengthening the foundations for lasting customer relationships while expanding its role in healthcare professionals’ everyday wardrobes.
FIGS’ Price Performance, Valuation & Estimates
Shares of FIGS have skyrocketed 82.5% over the past three months against the industry’s 5.8% decline.
Image Source: Zacks Investment Research
From a valuation standpoint, FIGS trades at a forward price-to-sales ratio of 3.66, above the industry’s average of 1.63. It has a Value Score of B.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for FIGS’ 2026 earnings implies 89.5% year-over-year growth, while the same for 2027 indicates a 1.9% decline. Estimates for 2026 and 2027 have been revised upward by 4 cents and 1 cent, respectively, over the past 30 days.
Image Source: Zacks Investment Research
FIGS currently carries a Zacks Rank #2 (Buy).
Other Key Picks
Genesco Inc. (GCO - Free Report) is a Nashville-based specialty retailer and branded company. It sells footwear and accessories through retail stores. The company sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Genesco’s current fiscal-year earnings indicates 62.1% growth from the year-ago actual. GCO delivered a trailing four-quarter average earnings surprise of 11.2%.
Designer Brands Inc. (DBI - Free Report) designs, produces and retails footwear and accessories. It offers shoes, boots, sandals, sneakers, socks, handbags and accessories. It currently carries a Zacks Rank #2.
The Zacks Consensus Estimate for Designer Brands’ current fiscal-year earnings and sales suggests growth of 225% and 0.6%, respectively, from the year-ago actuals. DBI delivered a trailing four-quarter average earnings surprise of 108.1%.
Urban Outfitters, Inc. (URBN - Free Report) is a lifestyle products and services company that sells fashion apparel, accessories, footwear, home goods and related offerings through a portfolio of global consumer brands. The company carries a Zacks Rank of 2 at present.
The Zacks Consensus Estimate for Urban Outfitters’ current fiscal-year earnings and sales suggests growth of 14% and 9.5%, respectively, from the year-ago actuals. URBN delivered a trailing four-quarter average earnings surprise of 9.7%.
View the Zacks #1 Rank List
Image: Shutterstock
FIGS' Product Innovation Strengthens Customer Loyalty & Engagement
Key Takeaways
FIGS, Inc. (FIGS - Free Report) is deepening its connection with healthcare professionals through products that combine practical improvements with fresh design. Its innovation strategy spans fit, fabric, comfort and functionality, alongside new styles and colors. Management highlighted positive customer feedback on fit enhancements, while wider-leg scrub pants, new waistband options and expanded layering choices are broadening the brand’s appeal.
The second-quarter 2026 customer metrics point to stronger engagement. Active customers increased 13.2% year over year to 3.1 million, while purchase frequency continued to improve. Trailing 12-month revenues per active customer rose 10.1% to a record $229. Returning customers were a particular source of strength, shopping more frequently and moving into higher spending levels.
This momentum extended across product categories. Scrubwear revenues grew 26.5% to $161.2 million, with gains across core franchises and limited-edition offerings. Non-scrubwear revenues increased 40.3% to $35.4 million, supported by underscrubs and outerwear. A broader wardrobe gives FIGS more opportunities to meet customers’ needs throughout the workday and encourage purchases beyond their essential scrubs.
Fabric development is reinforcing that strategy. FIGS is complementing its established FIONx offering with FORMx and the newer FIBREx to address different professional needs. Limited-edition launches also generate excitement while drawing attention to core products. Average order value rose 8.5% to $127, primarily reflecting pricing and favorable product mix, adding to the evidence of stronger customer spending.
These developments accompanied revenue growth of 28.8% to $196.6 million, marking FIGS’ third consecutive quarter of growth above 25%. The company also raised its full-year revenue growth outlook to approximately 20%. With an expanding assortment, positive product feedback and more frequent purchasing, FIGS is strengthening the foundations for lasting customer relationships while expanding its role in healthcare professionals’ everyday wardrobes.
FIGS’ Price Performance, Valuation & Estimates
Shares of FIGS have skyrocketed 82.5% over the past three months against the industry’s 5.8% decline.
Image Source: Zacks Investment Research
From a valuation standpoint, FIGS trades at a forward price-to-sales ratio of 3.66, above the industry’s average of 1.63. It has a Value Score of B.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for FIGS’ 2026 earnings implies 89.5% year-over-year growth, while the same for 2027 indicates a 1.9% decline. Estimates for 2026 and 2027 have been revised upward by 4 cents and 1 cent, respectively, over the past 30 days.
Image Source: Zacks Investment Research
FIGS currently carries a Zacks Rank #2 (Buy).
Other Key Picks
Genesco Inc. (GCO - Free Report) is a Nashville-based specialty retailer and branded company. It sells footwear and accessories through retail stores. The company sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Genesco’s current fiscal-year earnings indicates 62.1% growth from the year-ago actual. GCO delivered a trailing four-quarter average earnings surprise of 11.2%.
Designer Brands Inc. (DBI - Free Report) designs, produces and retails footwear and accessories. It offers shoes, boots, sandals, sneakers, socks, handbags and accessories. It currently carries a Zacks Rank #2.
The Zacks Consensus Estimate for Designer Brands’ current fiscal-year earnings and sales suggests growth of 225% and 0.6%, respectively, from the year-ago actuals. DBI delivered a trailing four-quarter average earnings surprise of 108.1%.
Urban Outfitters, Inc. (URBN - Free Report) is a lifestyle products and services company that sells fashion apparel, accessories, footwear, home goods and related offerings through a portfolio of global consumer brands. The company carries a Zacks Rank of 2 at present.
The Zacks Consensus Estimate for Urban Outfitters’ current fiscal-year earnings and sales suggests growth of 14% and 9.5%, respectively, from the year-ago actuals. URBN delivered a trailing four-quarter average earnings surprise of 9.7%.